Medibank share price halted after hackers claim to have taken customer data

Medibank shares have been halted after hackers made contact…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Medibank shares have been halted on Wednesday
  • This follows news that hackers claim to have taken customer data from the private health insurance giant
  • Medibank previously stated that it didn't believe customer data was removed from its systems

The Medibank Private Ltd (ASX: MPL) share price will be one to watch carefully in the coming days.

This follows the release of an update on its cybersecurity incident after the market close today.

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.

Image source: Getty Images

Why is the Medibank share price on watch?

Last week, Medibank revealed that it detected unusual activity on its network.

After taking immediate steps to contain the incident and engage specialised cyber security firms, the company stated that it didn't believe any customer data had been removed.

The company then went on to say that as a health company providing health insurance and health services, it holds a range of necessary personal information of customers. In light of this, it stressed that the protection of customers' data security is its highest priority.

Unfortunately, it may have failed with its highest priority, with the company no longer sure that customer data wasn't removed from its systems.

What's happened?

This afternoon, management revealed that it has received messages from a group that wishes to negotiate with the company regarding their alleged removal of customer data.

Medibank is treating the matter seriously and working urgently to establish if the claim is true.

As a result, the company has suspended its shares and they will remain that way until the matter is resolved.

Medibank's CEO, David Koczkar, commented:

I apologise and understand this latest distressing update will concern our customers. We have always said that we will prioritise responding to this matter as transparently as possible. "Our team has been working around the clock since we first discovered the unusual activity on our systems, and we will not stop doing that now. We will continue to take decisive action to protect Medibank customers, our people and other stakeholders.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Healthcare Shares

Up 60%: Why this exciting ASX stock could keep rising

This speculative stock could still have significant upside according to Bell Potter.

Read more »

A person holds their hands up through the middle of a rubber lifesaving ring while swimming in relatively calm conditions at a beach.
Healthcare Shares

Why this ASX healthcare high-flyer just dropped another 9% today

4DMedical shares are sliding again. Here’s what’s behind the drop.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

Mayne Pharma stock jumps 8% on strong Q3 update. Has it finally bottomed?

Mayne Pharma's share price has rebounded 32% since hitting a five-year low in March.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Healthcare Shares

Down 65%, are Cochlear shares a once-in-a-decade buying opportunity?

After a brutal drop, sentiment has turned negative. But looking beyond the next year, the long-term story may still be…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

A big milestone for this ASX biotech. Here's why the share price is moving

Mesoblast hits a key trial milestone...

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Healthcare Shares

Mesoblast shares in focus after key Phase 3 milestone for low back pain

Mesoblast shares are in focus after reaching a major patient recruitment milestone in its pivotal Phase 3 trial for chronic…

Read more »

CEO of a company talking.
Healthcare Shares

Regis Healthcare names Andrew Kinkade as new CEO

Regis Healthcare appoints Andrew Kinkade as CEO, unveiling new leadership strategy and key remuneration details.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Share Fallers

CSL shares crash to a 9-year low. Is it time to sell off my shares?

What's next for the beaten-down ASX biotech stock?

Read more »